Prot# RPC01-3204: A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Serverely Active Crohn's Disease

Hanauer, stephen B (PD/PI)
Yen, Eugene F (PD/PI)

Medicine, Gastroenterology Division

Project: Research project

Status	Finished
Effective start/end date	9/9/19 → 3/31/25

Funding

ICON Clinical Research, LLC (Prot# RPC01-3204 AMD 2 // Prot# RPC01-3204 AMD 2)
Celgene International II Sàrl (Prot# RPC01-3204 AMD 2 // Prot# RPC01-3204 AMD 2)